Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study
In: SKIN The Journal of Cutaneous Medicine, Jg. 2 (2018-02-23), S. S52
Online
unknown
Zugriff:
not available. Disclosures: Study sponsored by Novartis. Copyright 2018 SKIN
Titel: |
Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study
|
---|---|
Autor/in / Beteiligte Person: | Hébert, Jacques ; DeTakaosy, Frederica ; Papp, Kim ; Rihakova, Lenka ; Yang, William H. ; Sussman, Gordon ; Gulliver, Wayne ; Viera, Antonio ; Chambenoit, Olivier ; Lynde, Charles |
Link: | |
Zeitschrift: | SKIN The Journal of Cutaneous Medicine, Jg. 2 (2018-02-23), S. S52 |
Veröffentlichung: | National Society for Cutaneous Medicine, 2018 |
Medientyp: | unknown |
ISSN: | 2574-1624 (print) |
DOI: | 10.25251/skin.2.supp.52 |
Schlagwort: |
|
Sonstiges: |
|